Úsek pro vědu a výzkum

Seznam publikací

Autor
Název
Rok vydání

Publikace (3663)

[1]

Wei, A.H.; Döhner, H.; Pocock, C.; Montesinos, P.; Afanasyev, B.; Dombret, H.; Ravandi, F.; Sayar, H.; Jang, J.-H.; Porkka, K.; Selleslag, D.; Sandhu, I.; Turgut, M.; Giai, V.; Ofran, Y.; Çakar, M.K.; de Sousa, A.B.; Rybka, J.; Frairia, C.; Borin, L.; Beltrami, G.; Čermák, J.; et al.

Oral azacitidine maintenance therapy for acute myeloid leukemia in first remission

[rok vydání 2021, impact factor 91.245 ]

[2]

Bernard, E.; Nannya, Y.; Hasserjian, R.P.; Devlin, S.M.; Tuechler, H.; Medina-Martinez, J.S.; Yoshizato, T.; Shiozawa, Y.; Saiki, R.; Malcovati, L.; Levine, M.F.; Arango, J.E.; Zhou, Y.; Solé, F.; Cargo, C.A.; Haase, D.; Creignou, M.; Germing, U.; Zhang, Y.; Gundem, G.; Sarian, A.; van de Loosdrecht, A.A.; Jädersten, M.; Tobiasson, M.; Kosmider, O.; Follo, M.Y.; Thol, F.; Pinheiro, R.F.; Santini, V.; Kotsianidis, I.; Boultwood, J.; Santos, F.P.S.; Schanz, J.; Kasahara, S.; Ishikawa, T.; Tsurumi, H.; Takaori-Kondo, A.; Kiguchi, T.; Polprasert, C.; Bennett, J.M.; Klimek, V.M.; Savona, M.R.; Belickova, M.; et al.

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

[rok vydání 2020, impact factor 53.440 ]

[3]

Bernard, E.; Nannya, Y.; Hasserjian, R.P.; Devlin. S.M.; Tuechler, H.; Medina-Martinez, J.S.; Yoshizato, T.; Shiozawa, Y.; Saiki, R.; Malcovati, L.; Levine, M.F.; Arango, J.E.; Zhou, Y.; Solé, F.; Cargo, C.A.; Haase, D.; Creignou, M.; Germing, U.; Zhang, Y.; Gundem, G.; Sarian, A.; van de Loosdrecht, A.; Jädersten, M.; Tobiasson, M.; Kosmider, O.; Follo, M.Y.; Thol, F.; Pinheiro, R.F.; Santini, V.; Kotsianidis, I.; Boultwood, J.; Santos, F.P.S.; Schanz, J.; Kasahara, S.; Ishikawa, T.; Tsurumi, H.; Takaori-Kondo, A.; Kiguchi, T.; Polprasert, C.; Bennett, J.M.; Klimek, V.M.; Savona, M.R.; Belickova, M.; et al.

Author correction: implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes (Nature Medicine, (2020), 26, 10, (1549-1556), 10.1038/s41591-020-1008-z)

[rok vydání 2021, impact factor 53.440 ]

[4]

Bernard, E.; Nannya, Y.; Hasserjian, R.P.; Devlin, S.M.; Tuechler, H.; Medina-Martinez, J.S.; Yoshizato, T.; Shiozawa, Y.; Saiki, R.; Malcovati, L.; Levine, M.F.; Arango, J.E.; Zhou, Y.; Solé, F.; Cargo, C.A.; Haase, D.; Creignou, M.; Germing, U.; Zhang, Y.; Gundem, G.; Sarian, A.; van de Loosdrecht, A.A.; Jädersten, M.; Tobiasson, M.; Kosmider, O.; Follo, M.Y.; Thol, F.; Pinheiro, R.F.; Santini, V.; Kotsianidis, I.; Boultwood, J.; Santos, F.P.S.; Schanz, J.; Kasahara, S.; Ishikawa, T.; Tsurumi, H.; Takaori-Kondo, A.; Kiguchi, T.; Polprasert, C.; Bennett, J.M.; Klimek, V.M.; Savona, M.R.; Belickova, M.; et al.

Author correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes (Nature Medicine, (2020), 26, 10, (1549-1556), 10.1038/s41591-020-1008-z)

[rok vydání 2021, impact factor 53.440 ]

[5]

Kornum, B.R.; Kawashima, M.; Faraco, J.; Lin, L.; Rico, T.J.; Hesselson, S.; Axtell, R.C.; Kuipers, H.; Weiner, K.; Hamacher, A.; Kassack, M.U.; Han, F.; Knudsen, S.; Li, J.; Dong, X.; Winkelmann, J.; Plazzi, G.; Nevsimalova, S.; Hong, S.-C.; Honda, Y.; Honda, M.; Hogl, B.; Ton, T.G.N.; Montplaisir, J.; Bourgin, P.; Kemlink, D.; Huang, Y.-S.; Warby, S.; Einen, M.; Eshragh, J.L.; Miyagawa, T.; Desautels, A.; Ruppert, E.; Hesla, P.E.; Poli, F.; Pizza, F.; Frauscher, B.; Jeong, J.-H.; Lee, S.-P.; Strohl, K.P.; Longstreth Jr, W.T.; Kvale, M.; Dobrovolna, M.; Ohayon, M.M.; Nepom, G.T.; Wichmann, H.-E.; Rouleau, G.A.; Gieger, C.; Levinson, D.F.; Gejman, P.V.; Meitinger, T.; Peppard, P.; Young, T.; Jennum, P.b; Steinman, L.; Tokunaga, K.; Kwok, P.-Y.; Risch, N.; Hallmayer, J.; Mignot, E.

Common variants in P2RY11 are associated with narcolepsy

[rok vydání 2010, impact factor 35.532]

[6]

Saussele, S.; Richter, J.; Guilhot, J.; Gruber, F.X.; Hjorth-Hansen, H.; Almeida, A.; Janssen, J.J.W.M.; Mayer, J.; Koskenvesa, P.; Panayiotidis, P.; Olsson-Strömberg, U.; Martinez-Lopez, J.; Rousselot, P.; Vestergaard, H.; Ehrencrona, H.; Kairisto, V.; Machová Poláková, K.; Müller, M.C.; Mustjoki, S.; Berger, M.G.; Fabarius, A.; Hofmann, W.-K.; Hochhaus, A.; Pfirrmann, M.; Mahon, F.-X.; Ossenkoppele, G.; Pagoni, M.N.; Söderlund, S.; Escoffre-Barbe, M.; Etienne, G.; Dengler, J.; Huguet, F.; von Bubnoff, N.; Klamova, H.; et al.

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

[rok vydání 2018, impact factor 35.386 ]

[7]

Hallmayer, J.; Faraco, J.; Lin, L.; Hesselson, S.; Winkelmann, J.; Kawashima, M.; Mayer, G.; Plazzi, G.; Nevsimalova, S.; Bourgin, P.; Hong, S.S.-C.; Honda, Y.; Honda, M.; Hogl, B.; Longstreth, W.T. jr.; Montplaisir, J.; Kemlink, D.; Einen, M.; Chen, J.; Musone, S.L.; Akana, M.; Miyagawa, T.; Duan, J.; Desautels, A.; Erhardt, C.; Hesla, P.E.; Poli, F.; Frauscher, B.; Jeong, J.-H.; Lee, S.-P.; Ton, T.G.N.; Kvale, M.; Kolesar, L.; Dobrovolna, M.; Nepom, G.T.; Salomon, D.; Wichmann, H.-E.; Rouleau, G.A.; Gieger, C.; Levinson, D.F.; Gejman, P.V.; Meitinger, T.; Young, T.; Peppard, P.; Tokunaga, K.; Kwok, P.-Y.; Risch, N.; Mignot, E.

Narcolepsy is strongly associated with the T-cell receptor alpha locus

[rok vydání 2009, impact factor 34.284]

[8]

Hrachovinova, I.; Cambien, B.; Hafezi-Moghadam, A.; Kappelmayer, J.; Camphausen, R.T.; Widom, A.; Xia, L.; Kazazian jr, H.H.; Schaub, R.G.; McEver, R.P.; Wagner, D.D.

Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A

[rok vydání 2006, impact factor 30.550]

[9]

Lukas, J.; Parry, D.; Aagaard, L.; Mann, D.J.; Bartkova, J.; Strauss, M.; Peters, G.; Bartek, J.

Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16

[rok vydání 2006, impact factor 27.074]

[10]

Gagelmann, N.; Bacigalupo, A.; Rambaldi, A.; Hoelzer, D.; Halter, J.; Sanz, J.; Bonifazi, F.; Meijer, E.; Itälä-Remes, M.; Marková, M.; et al.

Haploidentical stem cell transplantation with posttransplant cyclophosphamide therapy vs other donor transplantations in adults with hematologic cancers: a systematic review and meta-analysis

[rok vydání 2019, impact factor 24.799 ]

[11]

Cornely O.A.; Alastruey-Izquierdo, A.; Arenz, D.; Chen, S.C.A.; Dannaoui, E.; Hochhegger, B.; Hoenigl, M.; Jensen, H.E.; Lagrou, K.; Lewis, R.E.; Mellinghoff, S.C.; Mer, M.; Pana, Z.D.; Seidel, D.; Sheppard, D.C.; Wahba, R.; Akova, M.; Alanio A.; Al-Hatmi, A.M.S.; Arikan-Akdagli, S.; Badali, H.; Ben-Ami, R.; Bonifaz, A.; Bretagne, S.; Castagnola, E.; Chayakulkeeree, M.; Colombo, A.L.; Corzo-Leon, D.E.; Drgona, L.; Groll, A.H.; Guinea, J.; Heussel, C.P.; Ibrahim, A.S.; Kanj, S.S.; Klimko, N.; Lackner, M.; Lamoth, F.; Lanternier, F.; Lass-Floerl, C.; Lee, D.G.; Lehrnbecher, T.; Lmimouni, B.E.; Mares, M.; Maschmeyer, G.; Meis, J.F.; Meletiadis, J.; Morrissey, C.O.; Nucci, M.; Oladele, R.; Pagano, L.; Pasqualotto, A.; Patel, A.; Racil, Z.; et al.

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

[rok vydání 2019, impact factor 24.446 ]

[12]

Danek, P.; Kardosova, M.; Janeckova, L.; Karkoulia, E.; Vanickova, K.; Fabisik, M.; Lozano-Asencio, C.; Benoukraf, T.; Tirado-Magallanes, R.; Zhou, Q.; Burocziova, M.; Rahmatova, S.; Pytlik, R.; et al.

Beta-catenin-TCF/LEF signaling promotes steady-state and emergency granulopoiesis via G-CSF receptor upregulation

[rok vydání 2020, impact factor 22.113 ]

[13]

Pagano, L.; Salmanton-García, J.; Marchesi, F.; López-García, A.; Lamure, S.; Itri , F.; Gomes-Silva, M.; Dragonetti, G.; Falces-Romero, I.; van Doesum, J.; Sili, U.; Labrador, J.; Calbacho, M.; Bilgin, Y.M.; Weinbergerová, B.; Serrano, L.; Ribera-Santa Susana, J.-M.; Malak, S.; Loureiro-Amigo, J.; Andreas Glenthøj, A.; Córdoba-Mascuñano, R.; Nunes-Rodrigues, R.; González-López, T.-J.; Karlsson, L.K.; Jiménez-Lorenzo, M.-J.; Hernández-Rivas, J.-Á.; Jaksic, O.; Ráčil, Z.; et al.

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA

[rok vydání 2022, impact factor 22.113 ]

[14]

Tarasco, E.; Bütikofer, L.; Friedman, K.D.; George, J.N.; Hrachovinova, I.; et al.

Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura

[rok vydání 2021, impact factor 22.113 ]

[15]

Pleyer, L.; Leisch, M.; Kourakli, A.; Padron, E.; Maciejewski, J.P.; Xicoy Cirici, B.; Kaivers, J.; Ungerstedt, J.; Heibl, S.; Patiou, P.; Hunter, A.M.; Mora, E.; Geissler, K.; Dimou, M.; Jimenez Lorenzo, M.-J.; Melchardt, T.; Egle, A.; Viniou, A.-N.; Patel, B.J.; Arnan, M.; Valent, P.; Roubakis, C.; Bernal del Castillo, T.; Galanopoulos, A.; Calabuig Muñoz, M.; Bonadies, N.; Medina de Almeida, A.; Cermak, J.; et al.

Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study

[rok vydání 2021, impact factor 18.959 ]

[16]

Bártek, J.; Bártkova, J.; Lukáš, J.

The retinoblastoma protein pathway and the restriction point

[rok vydání 2006, impact factor 18.043]

[17]

Kantarjian, H.M.; Thomas, X.G.; Dmoszynska, A.; Wierzbowska, A.; Mazur, G.; Mayer, J.; Cermak, J.; et al.

Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia

[rok vydání 2013, impact factor 18.038 ]

[18]

Battipaglia, G.; Labopin, M.; Kroger, N.; Vitek, A.; et al.

Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation

[rok vydání 2019, impact factor 17.794 ]

[19]

Pagano, L.; Salmanton-García, J.; Marchesi, F.; Busca, A.; Corradini, P.; Hoenigl, M.; Klimko, N.; Koehler, P.; Pagliuca, A.; Passamonti, F.; Verga, L.; Víšek, B.; Ilhan, O.; Nadali, G.; Weinbergerová, B.; Córdoba-Mascuñano, R.; Marchetti, M.; Collins, G.P.; Farina, F.; Cattaneo, C.; Cabirta, A.; Gomes-Silva, M.; Itri, F.; van Doesum, J.; Ledoux, M.P.; Čerňan, M.; Jakšić, O.; Duarte, R.F.; Magliano, G.; Omrani, A.S.; Fracchiolla, N.S.; Kulasekararaj, A.; Valković, T.; Poulsen, C.B.; Machado, M.; Glenthøj, A.; Stoma, I.; Ráčil, Z.; et al.

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

[rok vydání 2021, impact factor 17.388 ]

[20]

Musilova, K.; Devan, J.; Cerna, K.; Seda, V.; Pavlasova, G.; Sharma, S.; Oppelt, J.; Pytlik, R.; Prochazka, V.; Prouzova, Z.; Trbusek, M.; Zlamalikova, L.; Liskova, K.; Kruzova, L.; Jarosova, M.; Mareckova, A.; Kornauth, C.; Simonitsch-Klupp, I.; Schiefer, A.-I.; Merkel, O.; Mocikova, H.; Burda, P.; Polakova, K.M.; et al.

miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels

[rok vydání 2018, impact factor 16.601 ]